FALBERG KATHRYN E
SEC CIK 1206977 · EDGAR
BoughtSold
Most active insiders at RCUS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Jaen Juan C. | Pres | — | $9.22M |
| 2 | Jarrett Jennifer | COO | — | $2.17M |
| 3 | ROSEN TERRY J | CEO, Dir | — | $1.20M |
| 4 | Goeltz II Robert C. | CFO | — | $855.9K |
| 5 | Azoy Alexander | CAO | — | $432.5K |
| 6 | Tang Carolyn C. | GC | — | $318.5K |
| 7 | Markus Richard | Chief Medical Off | — | $210.1K |
| 8 | Ribas Antoni | Dir | — | — |
| 9 | Lambert Nicole | Dir | — | — |
| 10 | Lacey David L. | Dir | — | — |
| 13 | FALBERG KATHRYN E | Dir | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-12 16:28 | 2026-06-11 | RCUS | Arcus Biosciences, Inc. | FALBERG KATHRYN E | Dir | A - Grant | $0.00 | +5,700 | 44.3K | +15% | $0 |
| M | 2026-03-25 | 2026-03-23 | TTD | Trade Desk (The) | FALBERG KATHRYN E | Dir | D - Sale to Iss | $21.89 | -1,946 | 508 | -79% | -$42.6K |
| I | 2026-03-09 | 2026-03-05 | TTD | Trade Desk (The) | FALBERG KATHRYN E | Dir | S - Sale | $30.48 | -50.0K | 0 | -100% | -$1.52M |
| 2026-03-09 | 2026-03-05 | TTD | Trade Desk (The) | FALBERG KATHRYN E | Dir | S - Sale | $30.45 | -102.8K | 1,946 | -98% | -$3.13M | |
| D | 2025-06-12 | 2025-06-10 | RCUS | Arcus Biosciences, Inc. | FALBERG KATHRYN E | Dir | A - Grant | $0.00 | +13.3K | 68.6K | +24% | $0 |
| M | 2025-05-29 | 2025-05-27 | TTD | Trade Desk (The) | FALBERG KATHRYN E | Dir | A - Grant | $21.87 | +7,774 | 102.7K | +8% | +$170.0K |
| 2025-04-17 | 2025-04-15 | TTD | Trade Desk (The) | FALBERG KATHRYN E | Dir | A - Grant | $63.73 | +90 | 97.0K | +0.1% | +$5,736 | |
| 2024-08-15 | 2024-08-13 | TTD | Trade Desk (The) | FALBERG KATHRYN E | Dir | S - Sale | $98.17 | -150.0K | 96.9K | -61% | -$14.73M | |
| D | 2024-06-07 | 2024-06-06 | RCUS | Arcus Biosciences, Inc. | FALBERG KATHRYN E | Dir | A - Grant | $0.00 | +8,400 | 55.3K | +18% | $0 |
| M | 2024-05-30 | 2024-05-28 | TTD | Trade Desk (The) | FALBERG KATHRYN E | Dir | A - Grant | $23.22 | +4,301 | 246.3K | +2% | +$99.9K |
| D | 2024-03-12 | 2024-03-08 | TTD | Trade Desk (The) | FALBERG KATHRYN E | Dir | C - Cnv Deriv | $1.80 | +103.0K | 345.6K | +42% | +$185.5K |
| DM | 2024-03-12 | 2024-03-08 | TTD | Trade Desk (The) | FALBERG KATHRYN E | Dir | S - Sale | $81.90 | -103.0K | 242.6K | -30% | -$8.44M |
| D | 2023-06-16 | 2023-06-15 | RCUS | Arcus Biosciences, Inc. | FALBERG KATHRYN E | Dir | G - Gift | $0.00 | -50.5K | 40.1K | -56% | $0 |
| D | 2023-06-16 | 2023-06-15 | RCUS | Arcus Biosciences, Inc. | FALBERG KATHRYN E | Dir | A - Grant | $0.00 | +6,800 | 46.9K | +17% | $0 |
| M | 2023-05-30 | 2023-05-25 | TTD | Trade Desk (The) | FALBERG KATHRYN E | Dir | A - Grant | $17.12 | +5,836 | 241.8K | +2% | +$99.9K |
| 2023-02-08 | 2023-02-06 | TTD | Trade Desk (The) | FALBERG KATHRYN E | Dir | D - Sale to Iss | $59.83 | -21 | 236.8K | -0.0% | -$1,256 | |
| MI | 2022-12-05 | 2022-11-30+ | NUVB | Nuvation Bio Inc. | FALBERG KATHRYN E | Dir | P - Purchase | $1.93 | +250.0K | 207.0K | New | +$483.1K |
| D | 2022-06-16 | 2022-06-14 | RCUS | Arcus Biosciences, Inc. | FALBERG KATHRYN E | Dir | A - Grant | $0.00 | +4,100 | 90.6K | +5% | $0 |
| M | 2022-05-31 | 2022-05-26 | TTD | Trade Desk (The) | FALBERG KATHRYN E | Dir | A - Grant | $13.22 | +5,363 | 235.6K | +2% | +$70.9K |
| MI | 2021-11-23 | 2021-11-19 | TTD | Trade Desk (The) | FALBERG KATHRYN E | Dir | S - Sale | $108.59 | -150.0K | 71.7K | -68% | -$16.29M |
Purchase Sale Sale after option exercise All abbreviations